Arthur Frankel, MD
UT Southwestern.edu · Professor Internal Medicine-Hematology Oncology · University of Texas Southwestern Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Arthur Frankel, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:00 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT02915666 · A Clinical Trial of Patients With MelanomaUniversity of Texas Southwestern Medical Center · withdrawn · Melanoma · principal investigator
- Ph1NCT02138292 · A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type MelanomaUniversity of Texas Southwestern Medical Center · completed · Melanoma · principal investigator
- Ph1NCT02036281 · A Phase 1 Study of Substance P-Saporin in Terminal Cancer Patients With Intractable PainUniversity of Texas Southwestern Medical Center · completed · Terminally Ill, Histologically-confirmed Advanced Cancer, Pain, Intractable · principal investigator
- Ph1NCT01984255 · A Two-arm, Single Center Phase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma PatientsUniversity of Texas Southwestern Medical Center · terminated · Melanoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.